TL-HEM 150- ascorbic acid, .alpha.-tocopherol acetate, dl-, folic acid, cyanocobalamin, biotin, iron, cupric sulfate, and docusa

Страна: Соединенные Штаты

Язык: английский

Источник: NLM (National Library of Medicine)

Активный ингредиент:

ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R), .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) (.ALPHA.-TOCOPHEROL, DL- - UNII:7QWA1RIO01), FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8), CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204), BIOTIN (UNII: 6SO6U10H04) (BIOTIN - UNII:6SO6U10H04), IRON (UNII: E1UOL152H7) (IRON - UNII:E1UOL152H7), CUPRIC SULFATE (UNII: LRX7AJ16DT) (CUPRIC CATION - UNII:8CBV67279L), DOCUSATE SODIUM (UNII: F05Q2T2JA0)

Доступна с:

Trigen Laboratories, LLC

ИНН (Международная Имя):

ASCORBIC ACID

состав:

ASCORBIC ACID 500 mg

Администрация маршрут:

ORAL

Терапевтические показания :

This product is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy.

Обзор продуктов:

TL-HEM 150 is supplied in bottles of 90 caplets. PRODUCT CODE 13811-609-90

Статус Авторизация:

Dietary Supplement

Характеристики продукта

TL-HEM 150- ASCORBIC ACID, .ALPHA.-TOCOPHEROL ACETATE, DL-, FOLIC
ACID,
CYANOCOBALAMIN, BIOTIN, IRON, CUPRIC SULFATE, AND DOCUSATE SODIUM
TABLET, FILM
COATED
TRIGEN LABORATORIES, LLC
----------
TL-HEM 150
CAPLETS
RX ONLY
SUPPLEMENT FACTS TABLE
Other Ingredients: Microcrystalline Cellulose, Coating (Polyvinyl
Alcohol, Titanium Dioxide,
Polyethylene Glycol, Talc, FD&C Yellow #6 Lake, FD&C Blue #2 Lake),
Tripotassium
Citrate, Citric Acid, Povidone K30, Acacia, Stearic Acid, Fumed
Silica, and Magnesium
Stearate.
TL-HEM 150 is a hematinic multivitamin/multimineral dietary supplement
used to improve
the nutritional status of patients with iron deficiency.
CONTRAINDICATIONS
This product is contraindicated in patients with a known
hypersensitivity to any of the
components of this product. Hemochromatosis and hemosiderosis are
contraindications to iron therapy.
WARNINGS
WARNING: ACCIDENTAL OVERDOSE OF IRON-CONTAINING PRODUCTS IS A LEADING
CAUSE OF FATAL POISONING IN CHILDREN UNDER 6. KEEP THIS PRODUCT OUT OF
REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, CALL A DOCTOR OR
POISON
CONTROL CENTER IMMEDIATELY.
PRECAUTIONS
GENERAL: Folic acid alone is improper therapy in the treatment of
pernicious anemia and
other megaloblastic anemias where vitamin B12 is deficient. Folic acid
in doses above 1.0
mg daily may obscure pernicious anemia in that hematologic remission
can occur while
neurological manifestations remain progressive. Do not exceed
recommended daily
dose. Some patients affected with pernicious anemia may not respond to
orally
administered Vitamin B12 with intrinsic factor concentrate and there
is no known way to
predict which patients will respond. Periodic clinical assessment of
pernicious anemia
patients by a physician are recommended. If any symptoms of
intolerance to TL-HEM
150, including but not limited to nausea, vomiting, abdominal cramps
or rash occur, the
drug should be discontinued, as determined by a physician.
Biotin levels higher than the recommended daily allowance may cause
interference with
some la